CAPhO Hybrid Conference 2024


Click here to download the CAPhO 2024 Abstract Book.

Click here to download the Program at a Glance.

The Conference program will feature a diverse slate of plenary concurrent, and round table sessions to engage and inform participants of the advances in oncology pharmacy. New this year is the Oral Chemotherapy Management (OCM) Workshop taking place on Thursday, April 11. 

In addition to leading-edge education, the program will include two opportunities to interact with CAPhO’s leadership during CAPhO’s Annual General and Town Hall Breakfast meetings – your chance to discuss relevant questions affecting the association. And, as always, there will be a number of sponsored symposia taking place as well as networking events with the Welcome Reception on Friday evening and the CAPhO Dinner on Saturday evening. 

Click here for a sneak preview of the Conference’s Opening Plenary featuring Françoise Mathieu's presentation, "The Edge of Compassion: Staying Well While Working in Oncology".  Information on the rest of the program (other plenaries, concurrent sessions, round tables) will be available in October.

The program will be accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP).

April 8, 2024

On-demand symposia
Novartis On-Demand Symposium: A Day In The Life... Enhancing care for breast cancer patients
Christine Peragine
Dr. Sandeep Sehdev
Photo of Christine Peragine
Photo of Christine Peragine
Christine Peragine
Lead Pharmacist, Oral Anticancer Medication Program, Pharmacy, Sunnybrook Health Sciences Centre — Toronto, Ontario
Dr. Christine Peragine is the Lead Pharmacist for Sunnybrook’s Oral Anticancer Medication (OAM) Program at the Odette Cancer Centre, Toronto, Ontario, Canada. Christine graduated from the University of Toronto combined BScPhm-PharmD program in 2015 and started her PhD training and Antimicrobial Stewardship-Infectious Disease Pharmacy Fellowship in the same year. She has worked in Ambulatory Oncology since 2018 and is passionate about advancing pharmacy practice, research, and education. Over the course of her career, Dr. Peragine has spearheaded over 25 practice-based research initiatives, published over 30 unique abstracts, and presented at over 15 academic conferences. She has received over $110,000 CAD in grant funding and was the recipient of the 2022 Sunnybrook Practice-Based Research and Innovation Award of Inquiry. Her commitment to teaching is demonstrated by the number of students and trainees she has precepted (>30), and the creation and launch of clinical and research co-op opportunities with the OAM Team in Fall 2022.
Christine Peragine
Sunnybrook Health Sciences Centre, Toronto, Ontario
Photo of Dr. Sandeep Sehdev
Photo of Dr. Sandeep Sehdev
Dr. Sandeep Sehdev
Medical Oncologist, The Ottawa Hospital Cancer Centre — Ottawa, Ontario

Sandy Sehdev trained in medical oncology at the University of Toronto and The Princess Margaret Cancer Centre (1991).  

He worked at The William Osler Health System (Toronto) for 25 years (-2016) and while there was Chief of the Pharmacy & Therapeutics Committee, and lead of the clinical trials program (oncology) and continuing medical education (oncology). He was a past lead of CME for the Community Oncologists of Metropolitan Toronto (COMET), and a past Director of the Cancer Advocacy Coalition of Canada.  He is a co-founder of the Physician Alliance for Cancer Care and Treatment (Canada), an oncologist led advocacy coalition, and is a scientific advisor for the Canadian Cancer Survivor Network, and the Canadian Breast Cancer Network. 

He is currently a medical oncologist at The Ottawa Hospital Cancer Centre, focusing on the treatment of breast, prostate cancers and melanoma and lead for the breast cancer disease site.  He was the 2020 winner of the “Golden Throat” teaching award. 

Dr. Sandeep Sehdev
The Ottawa Hospital Cancer Centre, Ottawa, Ontario

The pharmacist has an important role to play as a member of the multidisciplinary team caring for patients with HR+HER2– breast cancer. Pharmacists have specific expertise that can improve clinic efficiency and patient care. 

Join us in this educational session as we outline the specific aspects of the pharmacist’s work with this patient population.

Learning Objectives:

  • Recognize the day-to-day clinical pharmacy activities associated with an advanced HR+HER2– breast cancer clinic
  • Describe patient-level recommendations required for advanced HR+HER2– breast cancer patients being treated with CDK4/6 inhibitors
  • Apply to practice specific steps in initiating or improving pharmacy services in such a setting

Presented by:

Christine Peragine PhD, PharmD, BScPhm, RPh
Pharmacist Lead, Oral Anticancer Medication Program
Sunnybrook Odette Cancer Centre
Toronto, Ontario